Status:
NOT_YET_RECRUITING
Engagement of Veterans With Lung Cancer
Lead Sponsor:
Palo Alto Veterans Institute for Research
Collaborating Sponsors:
United States Department of Defense
US Department of Veterans Affairs
Conditions:
Lung Cancer (NSCLC)
Lung Adenocarcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.
Detailed Description
This study aims to evaluate whether a lay health worker who provides education and support regarding goals of care and symptom management can improve health-related quality of life among Veterans with...
Eligibility Criteria
Inclusion
- Veteran patients with diagnosis of any stage of lung cancer;
- 18 years of age or older;
- English- or Spanish-speaking;
- can self-administer questionnaires in English or Spanish;
- valid telephone number;
- receiving oncology care at participating sites;
- currently newly diagnosed or receiving or having completed systemic anti-cancer therapy and/or radiation therapy within 12 months, defined as oral, injection, or intravenous therapy (chemotherapy, targeted therapy, or immunotherapy)
Exclusion
- no capacity to consent;
- actively receiving hospice care
Key Trial Info
Start Date :
October 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2032
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT07219251
Start Date
October 25 2025
End Date
December 31 2032
Last Update
October 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Veterans Affairs Palo Alto Health Care System (VAPAHCS)
Palo Alto, California, United States, 94304